Business Context and Reporting Period
Company: Apollo Investment Corporation (Note: Input metadata listed "Midcap Financial Investment Corp," but the filing text identifies the registrant as Apollo Investment Corporation).
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2015
Business Overview: Apollo Investment Corporation is a closed-end, externally managed, non-diversified business development company (BDC) and regulated investment company (RIC). It invests primarily in debt and equity securities of private middle-market companies, including secured and unsecured loans, mezzanine debt, and structured products.
Key Financial Metrics
| Metric | Amount (in thousands) |
|---|---|
| Total Assets | $3,219,294 |
| Total Investments (Fair Value) | $3,068,993 |
| Total Debt | $1,384,719 |
| Net Assets | $1,724,209 |
| Net Asset Value (NAV) Per Share | $7.56 |
| Cash and Foreign Currencies | $12,527 |
| Net Investment Income (9 Months) | $148,639 |
| Net Realized and Unrealized Losses (9 Months) | $(169,768) |
| Net Decrease in Net Assets from Operations (9 Months) | $(21,129) |
| Earnings Per Share (Basic & Diluted, 9 Months) | $(0.09) |
Material Changes vs. Prior Period
- Investment Income: Total investment income for the nine months ended December 31, 2015, was $294.4 million, a decrease of $37.1 million compared to $331.5 million in the prior year period. This decline was primarily driven by a $58.1 million decrease in interest income due to a lower income-bearing portfolio and increased non-accrual status investments, partially offset by a $25.2 million increase in dividend income.
- Net Expenses: Net expenses decreased to $145.8 million from $155.6 million year-over-year. This was driven by a $14.8 million reduction in management and incentive fees (net of waivers), partially offset by a $5.4 million increase in interest and debt expenses due to the issuance of 2025 Notes.
- Realized Losses: The Company recognized net realized losses of $120.4 million for the nine months ended December 31, 2015, compared to net realized losses of $3.2 million in the prior year. Significant losses were attributed to PlayPower Holdings, Inc. ($39.7 million), Molycorp, Inc. ($22.1 million), and Artsonig Pty Ltd ($21.7 million).
- Unrealized Losses: Net change in unrealized losses was $49.4 million for the current period, an improvement from $85.6 million in the prior year period.
- Share Repurchases: The Company repurchased 8,572,729 shares for $52.4 million during the nine-month period, reducing the share count from 236.7 million to 228.2 million.
Guidance, Outlook, Risks, and Unusual Items
- Share Repurchase Program: The Company completed a $50 million repurchase plan in August 2015 and approved a new $50 million plan in December 2015. As of December 31, 2015, $52.4 million had been utilized. Subsequent to the period end, an additional $10 million was repurchased.
- Debt Maturities: Convertible Notes totaling $200 million matured on January 15, 2016, and were repaid in full. Senior Secured Notes of $225 million matured and were repaid in October 2015.
- Legal Proceedings: The Company is a defendant in a lawsuit filed by the bankruptcy trustee of DSI Renal Holdings alleging fraudulent conveyance. The complaint seeks approximately $41 million in damages from the Company. The Company intends to vigorously defend itself and has filed a motion to dismiss.
- Non-Accrual Status: As of December 31, 2015, 2.5% of total investments at fair value were on non-accrual status, up from 0.1% at March 31, 2015.
- PIK Income: Payment-in-kind (PIK) income totaled $31.6 million for the nine months ended December 31, 2015. This non-cash income must be distributed to maintain RIC status, creating a cash flow requirement despite not being collected in cash.
Investor Verification Checklist
- Debt Repayment Capacity: Verify the Company's ability to repay the $200 million Convertible Notes maturing immediately after the reporting period (January 2016) and the $229 million in debt due within one year.
- Portfolio Credit Quality: Review the specific portfolio companies contributing to the $120.4 million in realized losses and the increase in non-accrual assets to assess future impairment risks.
- Cash Flow vs. Distributions: Analyze the sustainability of the $0.60 per share distribution rate given the significant non-cash PIK income ($31.6 million) and the net decrease in net assets from operations.
- Legal Exposure: Monitor the status of the DSI Renal Holdings litigation and the potential impact of the $41 million claimed damages.
- Share Count Reduction: Confirm the impact of the ongoing $50 million share repurchase plan on future earnings per share and NAV accretion.